Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

This strategy primarily targets individuals with bone diseases, metabolic‐related conditions, and specific physiological states such as obesity, the elderly, and pregnant women, using standardized serum 25(OH)D testing for objective assessment.

Source: Original paper. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Narrative review.

Narrative review

Discusses existing research; systematic-review methods have not been established by this classification.

Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Neuropathic Pain Comorbid Cognitive Impairment and Vitamin D: A Narrative Review From Mechanisms to Clinical Management

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Neuropathic Pain Comorbid Cognitive Impairment and Vitamin D: A Narrative Review From Mechanisms to Clinical Management

Narrative review · Food Science & Nutrition · 2026

Original publication title

Neuropathic Pain Comorbid Cognitive Impairment and Vitamin D: A Narrative Review From Mechanisms to Clinical Management

Nan Zhao; Yang Yang; Wanqiu Yu; Yuhang Zhu; Zhaoqiong Zhu

© 2026 The Author(s). Food Science & Nutrition published by Wiley Periodicals LLC.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

ABSTRACT

Neuropathic pain (NP) is not merely simple persistent pain but a complex pathological condition mediated by dysregulation across multiple systems, including the neuro‐immune‐endocrine axis. As a high‐intensity endogenous stressor, persistent pain signals can deplete cognitive resources and trigger neuroinflammation and central sensitization, leading to cognitive impairment (CI) characterized by attention deficits and impaired working memory. Currently, mainstream pharmacological treatments for NP carry risks of addiction and may exacerbate CI. Therefore, there is an urgent need to develop synergistic intervention strategies that address both pain management and cognitive protection.

Given that NP and CI share multiple pathological pathways, identifying interventions capable of simultaneously targeting multiple mechanisms has become a research hotspot. Vitamin D, a secosteroid hormone with both neuroprotective and immunoregulatory functions, is closely associated with an increased risk of NP and CI when deficient. Existing evidence suggests that Vitamin D may regulate the shared pathological mechanisms of these two diseases through multiple pathways, thus serving as a potential adjunctive strategy worthy of further investigation to alleviate the intertwined vicious cycle between NP and CI.

This paper systematically reviews the shared pathological mechanisms between NP and CI, summarizes the latest research progress, and explores the multi‐target mechanisms of Vitamin D in intervening in NP‐CI comorbidity, aiming to promote the application of this safe and cost‐effective nutritional strategy in dietary supplementations for NP‐CI comorbidity.

Authors’ abstract

ABSTRACT

Neuropathic pain (NP) is not merely simple persistent pain but a complex pathological condition mediated by dysregulation across multiple systems, including the neuro‐immune‐endocrine axis. As a high‐intensity endogenous stressor, persistent pain signals can deplete cognitive resources and trigger neuroinflammation and central sensitization, leading to cognitive impairment (CI) characterized by attention deficits and impaired working memory. Currently, mainstream pharmacological treatments for NP carry risks of addiction and may exacerbate CI. Therefore, there is an urgent need to develop synergistic intervention strategies that address both pain management and cognitive protection.

Given that NP and CI share multiple pathological pathways, identifying interventions capable of simultaneously targeting multiple mechanisms has become a research hotspot. Vitamin D, a secosteroid hormone with both neuroprotective and immunoregulatory functions, is closely associated with an increased risk of NP and CI when deficient. Existing evidence suggests that Vitamin D may regulate the shared pathological mechanisms of these two diseases through multiple pathways, thus serving as a potential adjunctive strategy worthy of further investigation to alleviate the intertwined vicious cycle between NP and CI.

This paper systematically reviews the shared pathological mechanisms between NP and CI, summarizes the latest research progress, and explores the multi‐target mechanisms of Vitamin D in intervening in NP‐CI comorbidity, aiming to promote the application of this safe and cost‐effective nutritional strategy in dietary supplementations for NP‐CI comorbidity.

Publication and source details

Original title: Neuropathic Pain Comorbid Cognitive Impairment and Vitamin D: A Narrative Review From Mechanisms to Clinical Management

Nan Zhao; Yang Yang; Wanqiu Yu; Yuhang Zhu; Zhaoqiong Zhu

Food Science & Nutrition · 2026

* Correspondence:
Yuhang Zhu (zhuyuhang_zmc@sina.com)
Zhaoqiong Zhu (zhuzhaoqiong@zmu.edu.cn)
© 2026 The Author(s). Food Science & Nutrition published by Wiley Periodicals LLC.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. National Natural Science Foundation of China10.13039/501100001809 82160223 Guizhou Provincial Basic Research Program (Natural Science) QKHJC(2026)002‐90 Zunyi Science and Technology Cooperation Fund HZ2026‐367 2025 Science and Technology Fund Project of Guizhou Provincial Health and Welfare Commission gzwkj2025‐381

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-07T14:32:52+00:00

DOI: 10.1002/fsn3.72440 · PMC13685529